Avitide Inc.

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio

Advantagene Closes $14.2m Series A Round Immuno-oncology firm Advantagene Inc. raised $14.2m through the sale of its Series A convertible preferred shares to undisclosed investors. National Securi

Relay Therapeutics has launched with $57m in Series A venture capital to identify new drug targets and to find new ways of addressing difficult targets by studying proteins in motion rather than looki

Start-Up Execs Acutus Medical Inc. Martin Chambers To: Chief Commercial Officer (September) From: VP, Global Sales, Spinal Modulation Inc. Phone: 858-673-1621 John Dahldorf To: CFO (September)